9996 — Peijia Medical Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeSmall Cap
- HK$2.49bn
- HK$1.71bn
- CNY441.13m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18.7 | 38.7 | 137 | 251 | 441 |
Cost of Revenue | |||||
Gross Profit | 12 | 25.2 | 95.7 | 176 | 325 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 246 | 442 | 735 | 693 | 872 |
Operating Profit | -227 | -404 | -599 | -443 | -431 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -532 | -2,069 | -574 | -398 | -392 |
Provision for Income Taxes | |||||
Net Income After Taxes | -532 | -2,069 | -574 | -408 | -393 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -532 | -2,069 | -574 | -408 | -393 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -532 | -2,069 | -574 | -408 | -393 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.14 | -4.37 | -0.868 | -0.605 | -0.578 |